BoironLTS:0DTF 73 FCF Margin % is 4.08% as of Dec. 2025, which is 32% below its 10-year median of 5.99. GuruFocus rates LTS:0DTF with a GF Score™ of 73/100 and a GF Value™ of €33.63 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, Boiron ranks better than 59.39% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Boiron's Free Cash Flow for the
six
months ended in Dec. 2025 was €10.4 Mil. Boiron's Revenue for the
six
months ended in Dec. 2025 was €255.5 Mil. Therefore, Boiron's FCF Margin % for the quarter that ended in Dec. 2025 was 4.08%.
The historical rank and industry rank for Boiron's FCF Margin % or its related term are showing as below:
LTS:0DTF'
s FCF Margin % Range Over the Past 10 Years
Min: 2.39 Med: 5.99 Max: 12.28
Current: 5.93
During the past 13 years, the highest FCF Margin % of Boiron was 12.28%. The lowest was 2.39%. And the median was 5.99%.
LTS:0DTF's FCF Margin % is ranked better than 59.39% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs LTS:0DTF: 5.93
Boiron FCF Margin % Related Terms
Boiron FCF Margin % Historical Data
* Premium members only.
The historical data trend for Boiron's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DTF vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boiron FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Boiron's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Boiron's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boiron (LTS:0DTF) has a FCF Margin % of 4.08% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Boiron and its competitors. This is 32% below median its historical median of 5.99. Over the past decade, Boiron's FCF Margin % has ranged from 2.39 to 12.28. According to the industry distribution chart, Boiron ranks #389 out of 958 companies in the Drug Manufacturers industry, placing it in the top 40.6%.
Is Boiron's FCF Margin % too high?
Boiron's current FCF Margin % of 4.08% is 32% below median its 10-year median of 5.99. Over the past 10 years, this metric has ranged from a low of 2.39 to a high of 12.28. The Drug Manufacturers industry median FCF Margin % is 2.45. Boiron's value of 4.08% is 66.9% above this industry median. Based on the distribution chart, Boiron ranks #389 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Boiron has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boiron's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Boiron ranks #389 out of 958 companies for FCF Margin %. This puts Boiron in the upper half of its industry. The industry median FCF Margin % is 2.45. Boiron's value of 4.08% is 66.9% above this benchmark. Historically, Boiron's own FCF Margin % has ranged from 2.39 to 12.28 over the past decade. While the company's 10-year median is 5.99 vs. the industry median of 2.45, Boiron has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boiron's current FCF Margin % of 4.08% is 66.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Boiron and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boiron's current FCF Margin % is 4.08%, which is 32% below median its own 10-year median of 5.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boiron stock overvalued right now?
Based on GuruFocus' analysis, Boiron (LTS:0DTF) is currently considered Modestly Undervalued. The stock's GF Value™ is €33.63, compared to a current price of €27.70 — trading 17.6% below its estimated fair value. The current FCF Margin % is 4.08%, which is 32% below median its 10-year median of 5.99 and 66.9% above the Drug Manufacturers industry median of 2.45. Boiron's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Boiron (LTS:0DTF), the current FCF Margin % is 4.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boiron (LTS:0DTF) Overvalued in 2026?
Based on GuruFocus' analysis, Boiron stock appears to be undervalued.
The current stock price of €27.70 is trading 17.6% below its estimated GF Value™ of €33.63.
GuruFocus considers Boiron to be Modestly Undervalued.
Key valuation signals for LTS:0DTF:
FCF Margin %: 4.08% (32% below median its 10-year median of 5.99)
GF Value™: €33.63 vs. price of €27.70 (17.6% below fair value)
Industry Position: 66.9% above the Drug Manufacturers median (#389 of 958)
No single metric tells the full story. See the LTS:0DTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
73GF Score
Get the complete analysis for LTS:0DTF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DTF has been successfully added to your 
